Form 4 for IRD Opus Genetics, Inc.
Accepted 2022-05-23 00:00:00 ET · period of report 2022-05-19 · accession 0001140361-22-020274 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-23 | 2022-05-19+ | IRD | Sooch Mina | Pres, CEO, Dir | P - Purchase | $2.04 | +25.0K | 412.5K | +6% | +$51.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-20 | P | A | 12,500 | $2.02 | 425,022 | D | — | — | (F2) The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.015 to $2.025. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2022-05-19 | P | A | 12,500 | $2.07 | 412,522 | D | — | — | (F1) The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.045 to $2.10. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. |